Drug Type miRNA |
Synonyms |
Target- |
Mechanism Gene expression modulators, RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Gatehouse Bio, Inc.Startup |
Active Organization Gatehouse Bio, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Huntington Disease | Discovery | US | Gatehouse Bio, Inc.Startup | 19 Sep 2022 |